![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Zbed3 | Mouse | 17beta-estradiol | multiple interactions | ISO | ZBED3 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of ZBED3 mRNA | CTD | PMID:30165855 | Zbed3 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of ZBED3 mRNA | CTD | PMID:16962184 | Zbed3 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Zbed3 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ZBED3 mRNA | CTD | PMID:21215274 | Zbed3 | Mouse | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Zbed3 (Rattus norvegicus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of ZBED3 mRNA | CTD | PMID:30071829 | Zbed3 | Mouse | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | ZBED3 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ZBED3 mRNA | CTD | PMID:28628672 | Zbed3 | Mouse | 6-propyl-2-thiouracil | increases expression | ISO | Zbed3 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of ZBED3 mRNA | CTD | PMID:24780913 | Zbed3 | Mouse | 6-propyl-2-thiouracil | decreases expression | ISO | Zbed3 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of ZBED3 mRNA | CTD | PMID:30047161 | Zbed3 | Mouse | aflatoxin B1 | affects expression | ISO | ZBED3 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of ZBED3 protein | CTD | PMID:20106945 | Zbed3 | Mouse | aflatoxin B1 | decreases expression | ISO | ZBED3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of ZBED3 mRNA | CTD | PMID:22100608 and PMID:27153756 | Zbed3 | Mouse | amiodarone | increases expression | ISO | ZBED3 (Homo sapiens) | 6480464 | Amiodarone results in increased expression of ZBED3 mRNA | CTD | PMID:19774075 | Zbed3 | Mouse | amitrole | decreases expression | ISO | Zbed3 (Rattus norvegicus) | 6480464 | Amitrole results in decreased expression of ZBED3 mRNA | CTD | PMID:30047161 | Zbed3 | Mouse | aristolochic acid A | decreases expression | ISO | ZBED3 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of ZBED3 mRNA | CTD | PMID:33212167 | Zbed3 | Mouse | atrazine | decreases expression | ISO | ZBED3 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of ZBED3 mRNA | CTD | PMID:22378314 | Zbed3 | Mouse | avobenzone | decreases expression | ISO | ZBED3 (Homo sapiens) | 6480464 | avobenzone results in decreased expression of ZBED3 mRNA | CTD | PMID:31016361 | Zbed3 | Mouse | benzo[a]pyrene | affects expression | EXP | | 6480464 | Benzo(a)pyrene affects the expression of ZBED3 mRNA | CTD | PMID:22641617 | Zbed3 | Mouse | benzo[a]pyrene | decreases expression | ISO | ZBED3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of ZBED3 mRNA | CTD | PMID:32234424 | Zbed3 | Mouse | bisphenol A | increases expression | ISO | Zbed3 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of ZBED3 mRNA | CTD | PMID:25181051 and PMID:33296240 | Zbed3 | Mouse | buta-1,3-diene | decreases expression | EXP | | 6480464 | 1 and 3-butadiene results in decreased expression of ZBED3 mRNA | CTD | PMID:29038090 | Zbed3 | Mouse | butanal | decreases expression | ISO | ZBED3 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of ZBED3 mRNA | CTD | PMID:26079696 | Zbed3 | Mouse | chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of ZBED3 mRNA | CTD | PMID:37019170 | Zbed3 | Mouse | cisplatin | decreases expression | ISO | ZBED3 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of ZBED3 mRNA | CTD | PMID:27392435 | Zbed3 | Mouse | copper atom | multiple interactions | EXP | | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ZBED3 mRNA | CTD | PMID:15467011 | Zbed3 | Mouse | copper atom | increases expression | ISO | Zbed3 (Rattus norvegicus) | 6480464 | Copper results in increased expression of ZBED3 mRNA | CTD | PMID:30556269 | Zbed3 | Mouse | copper(0) | multiple interactions | EXP | | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ZBED3 mRNA | CTD | PMID:15467011 | Zbed3 | Mouse | copper(0) | increases expression | ISO | Zbed3 (Rattus norvegicus) | 6480464 | Copper results in increased expression of ZBED3 mRNA | CTD | PMID:30556269 | Zbed3 | Mouse | copper(II) chloride | decreases expression | ISO | ZBED3 (Homo sapiens) | 6480464 | cupric chloride results in decreased expression of ZBED3 mRNA | CTD | PMID:38568856 | Zbed3 | Mouse | copper(II) sulfate | increases expression | ISO | ZBED3 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of ZBED3 mRNA | CTD | PMID:19549813 | Zbed3 | Mouse | crotonaldehyde | decreases expression | ISO | ZBED3 (Homo sapiens) | 6480464 | 2-butenal results in decreased expression of ZBED3 mRNA | CTD | PMID:20471460 | Zbed3 | Mouse | Cuprizon | increases expression | ISO | Zbed3 (Rattus norvegicus) | 6480464 | Cuprizone results in increased expression of ZBED3 mRNA | CTD | PMID:26577399 | Zbed3 | Mouse | cyclosporin A | decreases expression | ISO | ZBED3 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of ZBED3 mRNA | CTD | PMID:20106945 and PMID:25562108 | Zbed3 | Mouse | dexamethasone | increases expression | ISO | ZBED3 (Homo sapiens) | 6480464 | Dexamethasone results in increased expression of ZBED3 mRNA | CTD | PMID:25047013 | Zbed3 | Mouse | dexamethasone | multiple interactions | ISO | ZBED3 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ZBED3 mRNA | CTD | PMID:28628672 | Zbed3 | Mouse | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of ZBED3 mRNA | CTD | PMID:21266533 | Zbed3 | Mouse | dicrotophos | increases expression | ISO | ZBED3 (Homo sapiens) | 6480464 | dicrotophos results in increased expression of ZBED3 mRNA | CTD | PMID:28302478 | Zbed3 | Mouse | dorsomorphin | multiple interactions | ISO | ZBED3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBED3 mRNA | CTD | PMID:27188386 | Zbed3 | Mouse | endosulfan | decreases expression | ISO | Zbed3 (Rattus norvegicus) | 6480464 | Endosulfan results in decreased expression of ZBED3 mRNA | CTD | PMID:29391264 | Zbed3 | Mouse | flutamide | decreases expression | ISO | Zbed3 (Rattus norvegicus) | 6480464 | Flutamide results in decreased expression of ZBED3 mRNA | CTD | PMID:24793618 | Zbed3 | Mouse | gentamycin | decreases expression | ISO | Zbed3 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of ZBED3 mRNA | CTD | PMID:33387578 | Zbed3 | Mouse | indometacin | multiple interactions | ISO | ZBED3 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ZBED3 mRNA | CTD | PMID:28628672 | Zbed3 | Mouse | iron dichloride | decreases expression | ISO | ZBED3 (Homo sapiens) | 6480464 | ferrous chloride results in decreased expression of ZBED3 mRNA | CTD | PMID:35984750 | Zbed3 | Mouse | methimazole | decreases expression | ISO | Zbed3 (Rattus norvegicus) | 6480464 | Methimazole results in decreased expression of ZBED3 mRNA | CTD | PMID:30047161 | Zbed3 | Mouse | nickel atom | decreases expression | ISO | ZBED3 (Homo sapiens) | 6480464 | Nickel results in decreased expression of ZBED3 mRNA | CTD | PMID:24768652 and PMID:25583101 | Zbed3 | Mouse | paracetamol | decreases expression | ISO | Zbed3 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of ZBED3 mRNA | CTD | PMID:33387578 | Zbed3 | Mouse | phenobarbital | affects expression | ISO | ZBED3 (Homo sapiens) | 6480464 | Phenobarbital affects the expression of ZBED3 mRNA | CTD | PMID:19159669 | Zbed3 | Mouse | pregnenolone 16alpha-carbonitrile | decreases expression | ISO | Zbed3 (Rattus norvegicus) | 6480464 | Pregnenolone Carbonitrile results in decreased expression of ZBED3 mRNA | CTD | PMID:30047161 | Zbed3 | Mouse | quercetin | decreases expression | ISO | ZBED3 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of ZBED3 mRNA | CTD | PMID:21632981 | Zbed3 | Mouse | SB 431542 | multiple interactions | ISO | ZBED3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBED3 mRNA | CTD | PMID:27188386 | Zbed3 | Mouse | silver atom | decreases expression | EXP | | 6480464 | Silver results in decreased expression of ZBED3 mRNA | CTD | PMID:27131904 | Zbed3 | Mouse | silver(0) | decreases expression | EXP | | 6480464 | Silver results in decreased expression of ZBED3 mRNA | CTD | PMID:27131904 | Zbed3 | Mouse | sodium arsenate | decreases expression | EXP | | 6480464 | sodium arsenate results in decreased expression of ZBED3 mRNA | CTD | PMID:21795629 | Zbed3 | Mouse | sodium arsenate | increases expression | EXP | | 6480464 | sodium arsenate results in increased expression of ZBED3 mRNA | CTD | PMID:21795629 | Zbed3 | Mouse | sodium arsenite | decreases expression | ISO | ZBED3 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of ZBED3 mRNA | CTD | PMID:34032870 and PMID:38568856 | Zbed3 | Mouse | sulfadimethoxine | decreases expression | ISO | Zbed3 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in decreased expression of ZBED3 mRNA | CTD | PMID:30047161 | Zbed3 | Mouse | thioacetamide | decreases expression | ISO | Zbed3 (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of ZBED3 mRNA | CTD | PMID:34492290 | Zbed3 | Mouse | titanium dioxide | affects expression | EXP | | 6480464 | titanium dioxide affects the expression of ZBED3 mRNA | CTD | PMID:17656681 | Zbed3 | Mouse | titanium dioxide | decreases methylation | EXP | | 6480464 | titanium dioxide results in decreased methylation of ZBED3 promoter | CTD | PMID:35295148 | Zbed3 | Mouse | trichloroethene | increases expression | ISO | Zbed3 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of ZBED3 mRNA | CTD | PMID:33387578 | Zbed3 | Mouse | tungsten | decreases expression | EXP | | 6480464 | Tungsten results in decreased expression of ZBED3 mRNA | CTD | PMID:30912803 | Zbed3 | Mouse | urethane | decreases expression | ISO | ZBED3 (Homo sapiens) | 6480464 | Urethane results in decreased expression of ZBED3 mRNA | CTD | PMID:28818685 | Zbed3 | Mouse | valproic acid | increases methylation | ISO | ZBED3 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of ZBED3 gene | CTD | PMID:29154799 | Zbed3 | Mouse | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of ZBED3 mRNA | CTD | PMID:17292431 | Zbed3 | Mouse | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of ZBED3 mRNA | CTD | PMID:20546886 | Zbed3 | Mouse | valproic acid | affects expression | ISO | ZBED3 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of ZBED3 mRNA | CTD | PMID:25979313 | Zbed3 | Mouse | valproic acid | decreases expression | ISO | ZBED3 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of ZBED3 mRNA | CTD | PMID:19101580 more ... | Zbed3 | Mouse | valproic acid | multiple interactions | ISO | ZBED3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBED3 mRNA | CTD | PMID:27188386 | Zbed3 | Mouse | vorinostat | decreases expression | ISO | ZBED3 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of ZBED3 mRNA | CTD | PMID:27188386 | |